- Home
- PTHL vs IMCC Comparison
PTHL vs IMCC Comparison
Compare PTHL & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTHL
- IMCC
- Stock Information
- Founded
- PTHL 1998
- IMCC 1980
- Country
- PTHL China
- IMCC Israel
- Employees
- PTHL N/A
- IMCC N/A
- Industry
- PTHL
- IMCC Medicinal Chemicals and Botanical Products
- Sector
- PTHL
- IMCC Health Care
- Exchange
- PTHL Nasdaq
- IMCC Nasdaq
- Market Cap
- PTHL 8.8M
- IMCC 10.4M
- IPO Year
- PTHL 2024
- IMCC N/A
- Fundamental
- Price
- PTHL $0.60
- IMCC $1.34
- Analyst Decision
- PTHL
- IMCC
- Analyst Count
- PTHL 0
- IMCC 0
- Target Price
- PTHL N/A
- IMCC N/A
- AVG Volume (30 Days)
- PTHL 122.3K
- IMCC 1.3M
- Earning Date
- PTHL 01-01-0001
- IMCC 11-13-2025
- Dividend Yield
- PTHL N/A
- IMCC N/A
- EPS Growth
- PTHL N/A
- IMCC N/A
- EPS
- PTHL N/A
- IMCC N/A
- Revenue
- PTHL $448,196.00
- IMCC $38,430,631.00
- Revenue This Year
- PTHL N/A
- IMCC $47.12
- Revenue Next Year
- PTHL N/A
- IMCC $12.83
- P/E Ratio
- PTHL N/A
- IMCC N/A
- Revenue Growth
- PTHL N/A
- IMCC 5.08
- 52 Week Low
- PTHL $0.47
- IMCC $1.20
- 52 Week High
- PTHL $32.00
- IMCC $7.12
- Technical
- Relative Strength Index (RSI)
- PTHL 36.00
- IMCC 31.38
- Support Level
- PTHL $0.47
- IMCC $1.21
- Resistance Level
- PTHL $0.65
- IMCC $1.39
- Average True Range (ATR)
- PTHL 0.06
- IMCC 0.21
- MACD
- PTHL 0.04
- IMCC -0.02
- Stochastic Oscillator
- PTHL 63.46
- IMCC 9.32
About PTHL Pheton Holdings Ltd Class A Ordinary Shares
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.